Preparation of 2H-benzo[b][1,4]oxazin-3(4H)-ones as stearoyl CoA desaturase inhibitors.

  • Koltun D
  • Zablocki J
  • Vasilevich N
  • et al.
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Title compds. [I; R1 = H, (substituted) alkyl, cycloalkyl, alkenyl, alkynyl, alkoxy, heterocyclyl, aryl, heteroaryl; R2 = (substituted) alkyl, heterocyclyl, aryl, heteroaryl; R3, R4 = H, (substituted) alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl; X1 = O2C, NR'CO, O, S, SO2NR', etc.; R' = H, alkyl; L1, L2 = bond, (substituted) alkyleneoxy, alkylenethio, alkyleneimino; W = O, S], were prepd. Thus, N-[2-[6-(3,4-dichlorobenzylamino)-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl]ethyl]-2-hydroxyacetamide hydrochloride (multistep prepn. from 2-amino-4-nitrophenol, chloroacetyl chloride, ethanolamine, acetoxyacetic acid, and 3,4-dichlorobenzaldehyde given) inhibited stearoyl CoA desaturase with IC50 = 0.00139 μM. [on SciFinder(R)]

Cite

CITATION STYLE

APA

Koltun, D., Zablocki, J., Vasilevich, N., & Migulin, Vasily. (2009, October 8). Preparation of 2H-benzo[b][1,4]oxazin-3(4H)-ones as stearoyl CoA desaturase inhibitors. U.S. Pat. Appl. Publ. CV Therapeutics, Inc., USA .

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free